Offering Complementary Therapies to Patients: An Oncology Nurse’s Journey with Laura Freire, BSN, RN, OCN, HNB-BC, HTCP, CCAP, HSMI
Laura Freire, BSN, RN, OCN, HNB-BC, HTCP, CCAP, HSMI, Oncology Outpatient Center Staff Nurse, discusses how she learned about various complementary therapies and serves as an educator and point person for them at her oncology care center. Laura is joined by Laura Pole, MSN, RN, ONCS, senior clinical consultant at CancerChoices.
. First published on : Dec 05 2024How Oncology Nurses Reduce Our Fear: Reflections from a Cancer Coach and Thriver
Lindsay McDonell, a cancer coach, author, and CancerChoices volunteer guide, speaks about the critical role nurses play in helping people with cancer manage fear and find empowerment.
. First published on : Oct 31 2024What Would I Ask My Functional Medicine Doctor If I Had Cancer?
Should I ever have cancer, I would ask my functional medicine doctor to help me figure out if I had imbalances that could drive cancer processes.
. First published on : Oct 14 2024The Therapeutic Value of a Good Pain Assessment
Fully attending to your patient while assessing their pain can powerfully activate belief: a story for health professionals.
. First published on : Jul 25 2024New Efforts to Make Cell Therapies Like CAR-T More Accessible for Patients
Cell therapies like CAR-T are an extraordinary new class of drugs that have the potential to successfully treat cancer.
. Last modified on : Oct 14 2024The Evidence House: Valuing What the Physician Sees in Practice
Interpreting study results involves assessing the trade-offs between highly controlled situations and relevance to real life, then using the evidence that makes the most sense in the situation.
. Last modified on : Dec 27 2023Why Randomized Controlled Trials Don’t Always Tell the Real-World Story
RCTs are not always the best approach to get definitive answers to clinical questions.
. Last modified on : Nov 05 2024Complementary Therapies and Cancer: How Much Evidence Is Enough?
We view the use of science-informed, low-risk, affordable therapies as a reasonable option for patients. Stronger evidence of benefit is needed for therapies that are risky, expensive, or otherwise burdensome.
. Last modified on : Dec 27 2023Understanding Research Studies
Evidence that a therapy “works” runs a whole range from unreliable to trustworthy. In this post, we consider the design of research studies.
. Last modified on : Dec 27 2023CancerChoices Supplement and Therapies Database: Top-Rated on Quality and Trustworthiness
We received the highest rating among the sites evaluated for quality and trustworthiness of information on cancer complementary therapies.
. Last modified on : Dec 02 2024